NEW YORK – Pfizer says its vaccine continues to be effective against COVID-19 up to six months later. Pfizer and its German partner, BioNTech, announced updated results Thursday from their ongoing late-stage study of more than 44,000 volunteers. [TRENDING: Tax collector accused of stealing $400k | Land, ahoy: Boat falls onto Fla.
interstate | Gator takes dip in couple’s swimming pool] The companies said the vaccine was 91% effective against symptomatic disease and was even more protective in preventing severe disease.
Of 927 confirmed COVID-19 cases detected through March 13, 77 were among people who received the vaccine and 850 were among people who got dummy shots.